Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas System”

1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,742
Index total 30,257
Page 60 / 73

Quick answer

This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,742 results for “The Board of Regents of the University of Texas System” · 30,257 patents in full index Clear search

  1. US 7288369

    Replication competent hepatitis C virus and methods of use

    The Board of Regents of the University of Texas System · Granted Oct 30, 2007 · Expires Oct 25, 2027

    granted

  2. US 7288646

    USPA2 nucleic acid of Moraxella catarrhalis

    The Board of Regents of the University of Texas System · Granted Oct 30, 2007 · Expires Oct 25, 2027

    granted

  3. US 7285556

    Thienopyrimidine-based inhibitors of the src family

    The Board of Regents of the University of Texas System · Granted Oct 23, 2007 · Expires Oct 18, 2027

    granted

  4. US 7271148

    Inhibition of cellular proteases

    The Board of Regents of the University of Texas System · Granted Sep 18, 2007 · Expires Sep 13, 2027

    granted

  5. US 7271161

    Platinum complexes as antitumor agents in combination with biochemical modulation

    The Board of Regents of the University of Texas System · Granted Sep 18, 2007 · Expires Sep 13, 2027

    granted

  6. US 7261875

    Dendritic poly (amino acid) carriers and methods of use

    The Board of Regents of the University of Texas System · Granted Aug 28, 2007 · Expires Aug 23, 2027

    granted

  7. US 7256047

    Measurement of gluconeogenesis and intermediary metabolism using stable isotopes

    The Board of Regents of the University of Texas System · Granted Aug 14, 2007 · Expires Aug 9, 2027

    granted

  8. US 7252989

    Adenovirus supervector system

    The Board of Regents of the University of Texas System · Granted Aug 7, 2007 · Expires Aug 2, 2027

    granted

  9. US 7247316

    Compositions and methods for treating lymphoma

    The Board of Regents of the University of Texas System · Granted Jul 24, 2007 · Expires Jul 19, 2027

    granted

  10. US 7247303

    Selected antibody CDRs for binding to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Jul 24, 2007 · Expires Jul 19, 2027

    granted

  11. US 7244760

    Methods for preparation and use of psorospermin analogs

    The Board of Regents of the University of Texas System · Granted Jul 17, 2007 · Expires Jul 12, 2027

    granted

  12. US 7244617

    Diminishing viral gene expression by promoter replacement

    The Board of Regents of the University of Texas System · Granted Jul 17, 2007 · Expires Jul 12, 2027

    granted

  13. US 7244450

    Compositions and methods for treating lymphoma

    The Board of Regents of the University of Texas System · Granted Jul 17, 2007 · Expires Jul 12, 2027

    granted

  14. US 7238366

    Submicron liposome suspensions obtained from preliposome lyophilizates

    The Board of Regents of the University of Texas System · Granted Jul 3, 2007 · Expires Jun 28, 2027

    granted

  15. US 7229604

    Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging

    The Board of Regents of the University of Texas System · Granted Jun 12, 2007 · Expires Jun 7, 2027

    granted

  16. US 7223388

    Modified reoviral therapy

    The Board of Regents of the University of Texas System · Granted May 29, 2007 · Expires May 24, 2027

    granted

  17. US 7223787

    Prenylation inhibitors reduce host cell permissiveness to viral replication

    The Board of Regents of the University of Texas System · Granted May 29, 2007 · Expires May 24, 2027

    granted

  18. US 7223380

    Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging

    The Board of Regents of the University of Texas System · Granted May 29, 2007 · Expires May 24, 2027

    granted

  19. US 7220726

    Antifungal pimaricin compositions and therapeutic methods employing same

    The Board of Regents of the University of Texas System · Granted May 22, 2007 · Expires May 17, 2027

    granted

  20. US 7220853

    Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1

    The Board of Regents of the University of Texas System · Granted May 22, 2007 · Expires May 17, 2027

    granted

  21. US 7217795

    Tumor suppressor designated TS10q23.3

    The Board of Regents of the University of Texas System · Granted May 15, 2007 · Expires May 10, 2027

    granted

  22. US 7214519

    Screening method for identifying heme independent modulators of soluble guanylyl cyclase (sGC) activity using αβCys105 mutant sGC

    The Board of Regents of the University of Texas System · Granted May 8, 2007 · Expires May 3, 2027

    granted

  23. US 7211252

    Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists

    The Board of Regents of the University of Texas System · Granted May 1, 2007 · Expires Apr 26, 2027

    granted

  24. US 7204996

    Method of cancer treatment

    The Board of Regents of the University of Texas System · Granted Apr 17, 2007 · Expires Apr 12, 2027

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.